Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
CDX Holdings
Dr. George Poste Named Non-Executive Vice Chairman of CDX Holdings, Parent of Caris Diagnostics and Caris Molecular Diagnostics
August 13th, 2008
CDX Holdings, a newly-formed holding company that is the parent company of Caris Diagnostics (Caris Dx) and Caris Molecular Diagnostics (CMDx), announced that George Poste, D.V.M., Ph.D, F.R.C. Path, F.R.S., will be expanding his involvement with the company, serving as Non-Executive Vice Chairman and Chief Scientific Advisor of CDX Holdings and Non-Executive Chairman of CMDx. Dr. Poste has been a Director of Caris Dx, and now CDX Holdings, since November of 2006. He also acts as Senior Technical Advisor to Caris, Ltd., which owns a controlling stake in CDX Holdings. Dr. Poste is Chief Scientist of the Complex Adaptive Systems Initiative and Director of The Biodesign...
Source: Vaccine Weekly (2008-08-13)
|
